Fuze Health valuation, funding and investors

Fuze Health works in digital pharmacy solutions development, based in Fairfield, United States. It has about 220 employees.

Fairfield Series E

VALUATION · TODAY

$1.78B +0% after Series E

Range $579M – $3.77B · Grade C

TODAY

+12 MO

$1.00B

$2.00B

$3.00B

$4.00B

2020

2021

2022

2023

2024

2025

2026

2027

Series D $250M

Series E $200M

Valuation12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then

HEADCOUNT · TODAY220 employees

+90%6m growth

–1y growth

–2y growth

100

200

300

Data from Nov 2025

TODAY

Predicted in 1 yr $1.78B +0% vs today

Predicted next raise $292M if a round comes

Winding-down probability 0%

Last round: Series E · $200M · Jan 2022
Valuation at last round: $2.04B · implied
Headcount: 220 · growing
Grade: C
Founded: –

How VCMC values companies →

Fuze Health valuation today

VCMC values Fuze Health at $1.8B today, with a range of $579M to $3.8B and a grade of C. The valuation starts from its last funding round, a Series E round in Jan 2022.

Valuation by date (98 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Fuze Health: valuation by date, as the model would have shown it on each date
Date	Valuation	Range	Predicted in 1 yr	Phase	Headcount	Trend	Grade	Winding-down probability
6 Dec 2018	$455M	$299M – $899M	$591M (+30%)	after a round	–	unknown	B	0%
1 Jan 2019	$463M	$299M – $899M	$591M (+28%)	after a round	–	unknown	B	0%
1 Feb 2019	$474M	$299M – $899M	$591M (+25%)	after a round	–	unknown	B	0%
1 Mar 2019	$484M	$299M – $899M	$591M (+22%)	after a round	–	unknown	B	0%
1 Apr 2019	$494M	$299M – $899M	$591M (+20%)	after a round	–	unknown	B	0%
1 May 2019	$505M	$299M – $899M	$591M (+17%)	after a round	–	unknown	B	0%
1 Jun 2019	$517M	$299M – $899M	$591M (+14%)	after a round	–	unknown	B	0%
1 Jul 2019	$528M	$299M – $899M	$591M (+12%)	after a round	–	unknown	B	0%
1 Aug 2019	$540M	$299M – $899M	$591M (+9%)	after a round	–	unknown	B	0%
1 Sep 2019	$552M	$299M – $899M	$591M (+7%)	after a round	–	unknown	B	0%
1 Oct 2019	$564M	$299M – $899M	$591M (+5%)	after a round	–	unknown	B	0%
1 Nov 2019	$577M	$299M – $899M	$591M (+2%)	after a round	–	unknown	B	0%
1 Dec 2019	$589M	$299M – $899M	$591M (0%)	after a round	–	unknown	B	0%
1 Jan 2020	$591M	$287M – $899M	$591M (0%)	after a round	–	unknown	B	0%
1 Feb 2020	$591M	$274M – $899M	$591M (0%)	after a round	–	unknown	B	0%
1 Mar 2020	$591M	$262M – $899M	$591M (0%)	after a round	–	unknown	C	0%
1 Apr 2020	$591M	$250M – $899M	$591M (0%)	after a round	–	unknown	C	0%
1 May 2020	$591M	$239M – $899M	$591M (0%)	after a round	–	unknown	C	0%
1 Jun 2020	$591M	$229M – $899M	$591M (0%)	after a round	–	unknown	C	0%
1 Jul 2020	$591M	$219M – $899M	$591M (0%)	after a round	–	unknown	C	0%
1 Aug 2020	$591M	$209M – $899M	$591M (0%)	after a round	–	unknown	C	0%
1 Sep 2020	$591M	$199M – $899M	$591M (0%)	after a round	–	unknown	C	0%
1 Oct 2020	$591M	$190M – $899M	$591M (0%)	after a round	–	unknown	C	0%
1 Nov 2020	$591M	$182M – $899M	$591M (0%)	after a round	–	unknown	C	0%
1 Dec 2020	$591M	$174M – $899M	$591M (0%)	after a round	–	unknown	C	0%
4 Dec 2020	$1.0B	$869M – $1.5B	$1.3B (+30%)	after a round	–	unknown	A	0%
1 Jan 2021	$1.0B	$869M – $1.5B	$1.3B (+27%)	after a round	–	unknown	A	0%
1 Feb 2021	$1.0B	$869M – $1.5B	$1.3B (+25%)	after a round	–	unknown	A	0%
1 Mar 2021	$1.1B	$869M – $1.5B	$1.3B (+22%)	after a round	–	unknown	A	0%
1 Apr 2021	$1.1B	$869M – $1.5B	$1.3B (+19%)	after a round	–	unknown	A	0%
1 May 2021	$1.1B	$869M – $1.5B	$1.3B (+17%)	after a round	–	unknown	A	0%
1 Jun 2021	$1.1B	$869M – $1.5B	$1.3B (+14%)	after a round	–	unknown	A	0%
1 Jul 2021	$1.2B	$869M – $1.5B	$1.3B (+12%)	after a round	–	unknown	A	0%
1 Aug 2021	$1.2B	$869M – $1.5B	$1.3B (+9%)	after a round	–	unknown	A	0%
1 Sep 2021	$1.2B	$869M – $1.5B	$1.3B (+7%)	after a round	–	unknown	A	0%
1 Oct 2021	$1.2B	$869M – $1.5B	$1.3B (+5%)	after a round	–	unknown	A	0%
1 Nov 2021	$1.3B	$869M – $1.5B	$1.3B (+2%)	after a round	–	unknown	A	0%
1 Dec 2021	$1.3B	$869M – $1.5B	$1.3B (0%)	after a round	–	unknown	A	0%
1 Jan 2022	$1.3B	$833M – $1.5B	$1.3B (0%)	after a round	–	unknown	A	0%
28 Jan 2022	$2.0B	$1.4B – $3.8B	$2.7B (+30%)	after a round	–	unknown	B	0%
1 Feb 2022	$2.1B	$1.4B – $3.8B	$2.7B (+30%)	after a round	–	unknown	B	0%
1 Mar 2022	$2.1B	$1.4B – $3.8B	$2.7B (+27%)	after a round	–	unknown	B	0%
1 Apr 2022	$2.1B	$1.4B – $3.8B	$2.7B (+24%)	after a round	–	unknown	B	0%
1 May 2022	$2.2B	$1.4B – $3.8B	$2.7B (+22%)	after a round	–	unknown	B	0%
1 Jun 2022	$2.2B	$1.4B – $3.8B	$2.7B (+19%)	after a round	–	unknown	B	0%
1 Jul 2022	$2.3B	$1.4B – $3.8B	$2.7B (+16%)	after a round	–	unknown	B	0%
1 Aug 2022	$2.3B	$1.4B – $3.8B	$2.7B (+14%)	after a round	–	unknown	B	0%
1 Sep 2022	$2.4B	$1.4B – $3.8B	$2.7B (+11%)	after a round	–	unknown	B	0%
1 Oct 2022	$2.4B	$1.4B – $3.8B	$2.7B (+9%)	after a round	–	unknown	B	0%
1 Nov 2022	$2.5B	$1.4B – $3.8B	$2.7B (+6%)	after a round	–	unknown	B	0%
1 Dec 2022	$2.5B	$1.4B – $3.8B	$2.7B (+4%)	after a round	–	unknown	B	0%
1 Jan 2023	$2.6B	$1.4B – $3.8B	$2.7B (+2%)	after a round	–	unknown	B	0%
1 Feb 2023	$2.7B	$1.4B – $3.8B	$2.7B (0%)	after a round	–	unknown	B	0%
1 Mar 2023	$2.7B	$1.4B – $3.8B	$2.7B (0%)	after a round	–	unknown	B	0%
1 Apr 2023	$2.7B	$1.3B – $3.8B	$2.7B (0%)	after a round	–	unknown	B	0%
1 May 2023	$2.7B	$1.3B – $3.8B	$2.7B (0%)	after a round	–	unknown	B	0%
1 Jun 2023	$2.7B	$1.2B – $3.8B	$2.7B (0%)	after a round	–	unknown	B	0%
1 Jul 2023	$2.7B	$1.1B – $3.8B	$2.7B (0%)	after a round	–	unknown	B	0%
1 Aug 2023	$2.7B	$1.1B – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Sep 2023	$2.7B	$1.0B – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Oct 2023	$2.7B	$995M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Nov 2023	$2.7B	$950M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Dec 2023	$2.7B	$909M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Jan 2024	$2.7B	$867M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Feb 2024	$2.7B	$784M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Mar 2024	$2.7B	$748M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Apr 2024	$2.7B	$711M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 May 2024	$2.7B	$677M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Jun 2024	$2.7B	$643M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Jul 2024	$2.7B	$612M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Aug 2024	$2.7B	$582M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Sep 2024	$2.7B	$553M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Oct 2024	$2.7B	$526M – $3.8B	$2.7B (0%)	after a round	–	unknown	C	0%
1 Nov 2024	$2.7B	$500M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Dec 2024	$2.7B	$476M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Jan 2025	$2.7B	$452M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Feb 2025	$2.7B	$430M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Mar 2025	$2.7B	$411M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Apr 2025	$2.7B	$390M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 May 2025	$2.7B	$372M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Jun 2025	$2.7B	$353M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Jul 2025	$2.7B	$336M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Aug 2025	$2.7B	$319M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Sep 2025	$2.7B	$304M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Oct 2025	$2.7B	$289M – $3.8B	$2.7B (0%)	after a round	–	unknown	D	0%
1 Nov 2025	$2.7B	$275M – $3.8B	$2.7B (0%)	after a round	69	unknown	D	0%
1 Dec 2025	$2.7B	$261M – $3.8B	$2.7B (0%)	after a round	69	unknown	D	0%
1 Jan 2026	$2.7B	$248M – $3.8B	$2.7B (0%)	after a round	69	unknown	D	0%
1 Feb 2026	$2.7B	$236M – $3.8B	$2.7B (0%)	after a round	69	unknown	D	0%
1 Mar 2026	$2.7B	$225M – $3.8B	$2.7B (0%)	after a round	69	unknown	D	0%
1 Apr 2026	$2.7B	$959M – $3.8B	$2.7B (0%)	after a round	116	growing	C	0%
1 May 2026	$2.7B	$945M – $3.8B	$2.7B (0%)	after a round	116	growing	C	0%
1 Jun 2026	$2.7B	$930M – $3.8B	$2.7B (0%)	after a round	116	growing	C	0%
1 Jul 2026	$2.7B	$916M – $3.8B	$2.7B (0%)	after a round	116	growing	C	0%
1 Aug 2026	$2.7B	$902M – $3.8B	$2.7B (0%)	after a round	116	growing	C	0%
1 Sep 2026	$2.7B	$888M – $3.8B	$2.7B (0%)	after a round	116	growing	C	0%
1 Oct 2026	$2.7B	$874M – $3.8B	$2.7B (0%)	after a round	220	growing	C	0%
24 Oct 2026	$1.8B	$579M – $3.8B	$1.8B (0%)	after a round	220	growing	C	0%

Key facts about Fuze Health

Founded: Not on record
Headquarters: Fairfield, United States
Employees: about 220 +219% in a year
Total raised: $500M
Funding rounds: 3
Last round: Series E Jan 2022

Fuze Health funding history

Fuze Health has 3 funding rounds on record, from Dec 2018 to Jan 2022, $500M in total. The latest disclosed valuation is $1.00B post-money (Series D, Dec 2020).

Series E 27 Jan 2022
Led by SoftBank Vision Fund; with Madryn Asset Management, Sand Hill Angels, Flucas Ventures, What If Ventures, The Ultima Ventures.
Sources: alto.com
$200M
Series D 3 Dec 2020
Led by SoftBank Vision Fund; with Greenoaks, Jackson Square Ventures, OliveTree Capital, Zola Global.
Sources: alto.com
$250M
$1.00B post-money
Series C 5 Dec 2018
Led by Zola Global, Greenoaks; with Jackson Square Ventures, Olive Tree Capital, Flint Capital, Glilot Capital, Hack VC, Javelin Venture Partners, MHS Capital, NFX, Norwest, OurCrowd, Turtle Ventures, UpWest, Prescott Watson.
Sources: prweb.com
$50M

Fuze Health investors

22 investors have backed Fuze Health; Greenoaks, SoftBank Vision Fund and Zola Global led at least one round.

Greenoaks lead, 2 rounds
SoftBank Vision Fund lead, 2 rounds
Zola Global lead, 2 rounds
Flint Capital
Flucas Ventures
MHS Capital
Norwest
OliveTree Capital
Prescott Watson
The Ultima Ventures
Turtle Ventures

What Fuze Health does

Fuze Health works in drug stores & pharmacies, with 12 recorded offerings and customers in healthcare.

Fuze Corporate Inc., known as Fuze Health, is a United States technology company engaged in healthcare technology solutions, including digital pharmacy services, clinical services, and emerging technologies for healthcare delivery. The company serves health systems, employers, health plans, and life sciences companies, and operates as a Mail Service Pharmacy and Specialty Pharmacy. Fuze Health is accredited and maintains a nationwide pharmacy footprint.

Description from Veridion's company data.

Products and services

Digital Pharmacy Solutions Development
Prescription Fulfillment Services
Patient Engagement Tools Development
Clinical Services
Disease Screening Services
Genomics Services
Telehealth Services
Digital Pharmacy Services
Mail Service Pharmacy Services
Specialty Pharmacy Services
Healthcare Technology Development
Healthcare Research and Development

Markets

Healthcare

Technology

API-Powered Prescription Fulfillment

Certifications

HIPAA compliant
CCPA compliant

Business model

Business-to-Business
Business-to-Consumer
Service Provider
Healthcare

Industry codes (NAICS)

456110 Pharmacies and Drug Retailers 50% match
621999 All Other Miscellaneous Ambulatory Health Care Services 30% match
541512 Computer Systems Design Services 20% match

Questions about Fuze Health

What is Fuze Health worth?

Valuation $1.8B (range $579M to $3.8B), as of 24 Oct 2026. The last disclosed valuation was $1.00B (Series D, Dec 2020).

Has Fuze Health raised money?

Fuze Health has 3 funding rounds on record, from Dec 2018 to Jan 2022, $500M in total. The latest disclosed valuation is $1.00B post-money (Series D, Dec 2020).

Who has invested in Fuze Health?

Greenoaks, SoftBank Vision Fund, Zola Global, Jackson Square Ventures, Flint Capital and Flucas Ventures, and 16 more. Lead investors include Greenoaks, SoftBank Vision Fund and Zola Global.

How many people work at Fuze Health?

About 220, up 219% over the last year. Headcount grew from 69 in Nov 2025 to 220 in Sep 2026.

What does Fuze Health do?

Fuze Health works in drug stores & pharmacies, with 12 recorded offerings and customers in healthcare. Its main offerings are digital pharmacy solutions development, prescription fulfillment services and patient engagement tools development.

Where is Fuze Health based?

Fuze Health is based in Fairfield, United States; its founding year is not on record. It has about 220 employees, up 219% over the last year.

How we value companies Report an issue